Antiphospholipid syndrome, a condition characterized by one or more thrombotic or
pregnancy-related clinical features in association with medium to high levels of …

Antiphospholipid Syndrome (APS) has been widely recognized as a risk factor for the
recurrence of both thrombosis and pregnancy losses; however the optimal treatment of …

OBJECTIVE To compare the efficacy of unfractionated heparin and low molecular weight
heparin in the in vitro binding of antiphospholipid antibodies obtained from the sera of …

Prothrombotic disorders are believed to be important contributors to the etiology of peri-and
neonatal arterial ischemic stroke and sinovenous thrombosis, which may lead to life-long …

The exact prevalence of recurrent miscarriage is dependent on its definition, but it can be
estimated to occur in 1% to 3% of pregnancies. Extending the definition of miscarriage to the …

Antiphospholipid antibodies are a heterogeneous group of autoantibodies directed against
phospholipids (principally of negative charge), phospholipids bound to proteins …

Pregnancy predisposes to venous thromboembolism for several reasons. These include a
change in the balance between procoagulant and anticoagulant factors in the blood. Any …

Starting from their first description, antiphospholipid antibodies (aPL) were associated with
repeated miscarriages and fetal losses. Other complications of pregnancy like preterm birth …

Antiphospholipid syndrome (APS) is defined as the presence of venous or arterial
thromboses, and/or recurrent miscarriage, with evidence of antiphospholipid antibodies …

El síndrome antifosfolipídico fue definido hace 20 años por Hughes como el estado
trombofílico (arterial y/o venoso) y/o de pérdidas fetales recurrentes en presencia de …